These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2975124)
21. [Effect of triftazin and haloperidol on the activity of phenazepam]. Molodavkin GM; Belousova SG Biull Eksp Biol Med; 1983 Aug; 96(8):64-6. PubMed ID: 6882908 [TBL] [Abstract][Full Text] [Related]
22. [Effect of psychotropic drugs on sleep disorders in rats during alcohol withdrawal]. Burov IuV; Viglinskaia IV Biull Eksp Biol Med; 1981 Jun; 91(6):689-91. PubMed ID: 7196780 [TBL] [Abstract][Full Text] [Related]
23. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol. Bošković M; Vovk T; Koprivšek J; Plesničar BK; Grabnar I Nutr Neurosci; 2016 May; 19(4):156-61. PubMed ID: 25056532 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V; JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311 [TBL] [Abstract][Full Text] [Related]
25. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders. Schatzberg AF; Cole JO Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529 [No Abstract] [Full Text] [Related]
26. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331 [TBL] [Abstract][Full Text] [Related]
27. Letter: Double-blind trial of lithium carbonate and haloperidol in Huntington's chorea. Leonard DP; Kidson MA; Shannon PJ; Brown J Lancet; 1974 Nov; 2(7890):1208-9. PubMed ID: 4139622 [No Abstract] [Full Text] [Related]
28. Lithium in treatment failures. Van Putten T; Sanders DG J Nerv Ment Dis; 1975 Oct; 161(4):255-64. PubMed ID: 1100782 [TBL] [Abstract][Full Text] [Related]
29. [Effect of psychotropic drugs on the pharmacokinetics of lithium]. Samoĭlov NN; Liubimov BI; Sholokhov VM; Petrov VM Biull Eksp Biol Med; 1980 Jun; 89(6):696-8. PubMed ID: 6104997 [TBL] [Abstract][Full Text] [Related]
30. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614 [TBL] [Abstract][Full Text] [Related]
31. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987 [TBL] [Abstract][Full Text] [Related]
32. [The correction of the hepatotoxicity of antitubercular preparations with tocopherol acetate and riboxin]. Skakun NP; Slivka IuI Eksp Klin Farmakol; 1992; 55(3):52-4. PubMed ID: 1458166 [TBL] [Abstract][Full Text] [Related]
33. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs]. Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127 [No Abstract] [Full Text] [Related]
34. [Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders]. Maksimenko TV Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):737-40. PubMed ID: 6880505 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE; Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841 [TBL] [Abstract][Full Text] [Related]
36. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
37. Antipsychotic drug effects on brain morphology in first-episode psychosis. Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M; Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403 [TBL] [Abstract][Full Text] [Related]
38. [The effect of fenazepam and sidnocarb in the phantom pain syndrome]. Danilova EI; Grafova VN; Reshetnik VK Eksp Klin Farmakol; 1994; 57(1):11-3. PubMed ID: 7908239 [TBL] [Abstract][Full Text] [Related]
39. Lithium and haloperidol. Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447 [No Abstract] [Full Text] [Related]
40. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]